ADVENTRX Pharmaceuticals announces 6-month stability data for Exelbine ADVENTRX Pharmaceuticals, Inc. The 6-month balance data are on the right track to aid the submission of the brand new Drug Application for Exelbine. Culley, CEO of ADVENTRX. ‘After we have the 12-month data, we will send the Exelbine NDA, which we expect will take place in the fourth quarter of this full year.’.Here are some of the queries you may want to read: Question: What is hair transplant? Solution: The technique is easy yet specialized. A Strip Technique or Follicular Unit Extraction Method employs locks extracted from the back of the top and transplants locks to the bald areas. Issue: What is the procedure of hair transplant? Solution: A patient knows the conditions through the locks transplant and an area anesthesia can be used in minute quantity in order that patient is fully conscious.